Next Article in Journal
Uropathogenic Escherichia coli Biofilm-Forming Capabilities are not Predictable from Clinical Details or from Colonial Morphology
Previous Article in Journal
From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation
Previous Article in Special Issue
“I Actually Don’t Know What HIV Is”: A Mixed Methods Analysis of College Students’ HIV Literacy
Due to scheduled maintenance work on our core network, there may be short service disruptions on this website between 16:00 and 16:30 CEST on September 25th.
Article

Disparities in Hepatitis B Vaccine Coverage by Race/Ethnicity: The National Health and Nutrition Examination Survey (NHANES) 2015–2016

1
Department of Epidemiology and Biostatistics, School of Public Health, Jackson State University, Jackson, MS 39213, USA
2
School of Nursing, Johns Hopkins University, 525 N. Wolfe Street, Baltimore, MD 21205, USA
*
Author to whom correspondence should be addressed.
Received: 31 December 2019 / Revised: 7 April 2020 / Accepted: 14 April 2020 / Published: 16 April 2020
(This article belongs to the Special Issue Infectious Disease Epidemiology)
Hepatitis B virus (HBV) infection is the most common form of viral hepatitis and remains a global public health problem, even though the HBV vaccine is available. HBV leads to chronic liver disease, including cirrhosis, liver cancer, and death. This study aimed to identify disparities in HBV vaccine coverage with the serological test by race/ethnicity, adjusting for gender and age. In this study, 5735 adult participants were included, obtaining data from the National Health and Nutrition Examination Survey (NHANES), 2015–2016. Proc survey frequency, bivariate- and multivariate logistic regression in the weighted sample were performed due to the complex survey design of NHANES. Data were analyzed using SAS, version 9.2.4. The overall prevalence of HBV vaccine coverage was only 23.3% (95% CI: 20.7%, 25.9%). In a multivariate logistic regression model, data showed that Mexican Americans (OR 0.57, 95% CI: 0.38, 0.86) and African Americans (OR 0.70, 95% CI 0.56, 0.84) had lower vaccine coverage compared to Whites. Females had (OR 1.55, 95% CI: 1.30, 1.85) higher vaccine coverage compared to men. Older age groups (30–49 years) (OR 0.41, 95% CI: 0.32, 0.52) and age group ≥ 50 years (OR 0.18, 95% CI 0.14, 0.23) had lower vaccine coverage compared to younger adults aged 18–29 years. View Full-Text
Keywords: hepatitis B virus; HBV vaccine; race/ethnicity; health disparity; NHANES data hepatitis B virus; HBV vaccine; race/ethnicity; health disparity; NHANES data
Show Figures

Figure 1

MDPI and ACS Style

Bhuiyan, A.R.; Kabir, N.; Mitra, A.K.; Ogungbe, O.; Payton, M. Disparities in Hepatitis B Vaccine Coverage by Race/Ethnicity: The National Health and Nutrition Examination Survey (NHANES) 2015–2016. Diseases 2020, 8, 10. https://0-doi-org.brum.beds.ac.uk/10.3390/diseases8020010

AMA Style

Bhuiyan AR, Kabir N, Mitra AK, Ogungbe O, Payton M. Disparities in Hepatitis B Vaccine Coverage by Race/Ethnicity: The National Health and Nutrition Examination Survey (NHANES) 2015–2016. Diseases. 2020; 8(2):10. https://0-doi-org.brum.beds.ac.uk/10.3390/diseases8020010

Chicago/Turabian Style

Bhuiyan, Azad R., Nusrat Kabir, Amal K. Mitra, Oluwabunmi Ogungbe, and Marinelle Payton. 2020. "Disparities in Hepatitis B Vaccine Coverage by Race/Ethnicity: The National Health and Nutrition Examination Survey (NHANES) 2015–2016" Diseases 8, no. 2: 10. https://0-doi-org.brum.beds.ac.uk/10.3390/diseases8020010

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop